IBDEI1JX ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,25145,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,25145,1,2,0)
;;=2^High Intensity Bhv Counsel for STD Prev,30 min
;;^UTILITY(U,$J,358.3,25145,1,4,0)
;;=4^G0445
;;^UTILITY(U,$J,358.3,25146,0)
;;=G0459^^88^1130^41^^^^1
;;^UTILITY(U,$J,358.3,25146,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,25146,1,2,0)
;;=2^Inpt TH Pharm Mgmt
;;^UTILITY(U,$J,358.3,25146,1,4,0)
;;=4^G0459
;;^UTILITY(U,$J,358.3,25147,0)
;;=G0446^^88^1130^7^^^^1
;;^UTILITY(U,$J,358.3,25147,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,25147,1,2,0)
;;=2^Annual Intense Bhv Tx for Cardio Dx,15 min
;;^UTILITY(U,$J,358.3,25147,1,4,0)
;;=4^G0446
;;^UTILITY(U,$J,358.3,25148,0)
;;=G0447^^88^1130^13^^^^1
;;^UTILITY(U,$J,358.3,25148,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,25148,1,2,0)
;;=2^Bhv Counsel for Obesity,15 min
;;^UTILITY(U,$J,358.3,25148,1,4,0)
;;=4^G0447
;;^UTILITY(U,$J,358.3,25149,0)
;;=G0506^^88^1130^17^^^^1
;;^UTILITY(U,$J,358.3,25149,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,25149,1,2,0)
;;=2^Comp Assmt Care Plan CCM Svc
;;^UTILITY(U,$J,358.3,25149,1,4,0)
;;=4^G0506
;;^UTILITY(U,$J,358.3,25150,0)
;;=G0513^^88^1130^57^^^^1
;;^UTILITY(U,$J,358.3,25150,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,25150,1,2,0)
;;=2^Prolong Prev Outpt Svc,1st 30 min
;;^UTILITY(U,$J,358.3,25150,1,4,0)
;;=4^G0513
;;^UTILITY(U,$J,358.3,25151,0)
;;=G0514^^88^1130^58^^^^1
;;^UTILITY(U,$J,358.3,25151,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,25151,1,2,0)
;;=2^Prolong Prev Outpt Svc,Ea Addl 30 min
;;^UTILITY(U,$J,358.3,25151,1,4,0)
;;=4^G0514
;;^UTILITY(U,$J,358.3,25152,0)
;;=G2086^^88^1130^51^^^^1
;;^UTILITY(U,$J,358.3,25152,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,25152,1,2,0)
;;=2^Outpt Based Opioid Tx,70 min
;;^UTILITY(U,$J,358.3,25152,1,4,0)
;;=4^G2086
;;^UTILITY(U,$J,358.3,25153,0)
;;=G2087^^88^1130^50^^^^1
;;^UTILITY(U,$J,358.3,25153,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,25153,1,2,0)
;;=2^Outpt Based Opioid Tx,60 min
;;^UTILITY(U,$J,358.3,25153,1,4,0)
;;=4^G2087
;;^UTILITY(U,$J,358.3,25154,0)
;;=G2088^^88^1130^52^^^^1
;;^UTILITY(U,$J,358.3,25154,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,25154,1,2,0)
;;=2^Outpt Based Opioid Tx,Ea Addl 30 min
;;^UTILITY(U,$J,358.3,25154,1,4,0)
;;=4^G2088
;;^UTILITY(U,$J,358.3,25155,0)
;;=U07.1^^89^1131^1
;;^UTILITY(U,$J,358.3,25155,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,25155,1,3,0)
;;=3^Confirmed COVID-19
;;^UTILITY(U,$J,358.3,25155,1,4,0)
;;=4^U07.1
;;^UTILITY(U,$J,358.3,25155,2)
;;=^5159070
;;^UTILITY(U,$J,358.3,25156,0)
;;=U09.9^^89^1131^2
;;^UTILITY(U,$J,358.3,25156,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,25156,1,3,0)
;;=3^Post COVID-19 Condition,Unspec
;;^UTILITY(U,$J,358.3,25156,1,4,0)
;;=4^U09.9
;;^UTILITY(U,$J,358.3,25156,2)
;;=^5161298
;;^UTILITY(U,$J,358.3,25157,0)
;;=Z20.822^^89^1132^1
;;^UTILITY(U,$J,358.3,25157,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,25157,1,3,0)
;;=3^Contact w/ & Exposure to COVID-19
;;^UTILITY(U,$J,358.3,25157,1,4,0)
;;=4^Z20.822
;;^UTILITY(U,$J,358.3,25157,2)
;;=^5160187
;;^UTILITY(U,$J,358.3,25158,0)
;;=J20.8^^89^1133^1
;;^UTILITY(U,$J,358.3,25158,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,25158,1,3,0)
;;=3^Bronchitis,Acute d/t Other Spec Organisms
;;^UTILITY(U,$J,358.3,25158,1,4,0)
;;=4^J20.8
;;^UTILITY(U,$J,358.3,25158,2)
;;=^5008194
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1JX 3751 printed Apr 09, 2024@21:27:18 Page 2
IBDEI1JX ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,25145,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,25145,1,2,0)
+4 ;;=2^High Intensity Bhv Counsel for STD Prev,30 min
+5 ;;^UTILITY(U,$J,358.3,25145,1,4,0)
+6 ;;=4^G0445
+7 ;;^UTILITY(U,$J,358.3,25146,0)
+8 ;;=G0459^^88^1130^41^^^^1
+9 ;;^UTILITY(U,$J,358.3,25146,1,0)
+10 ;;=^358.31IA^4^2
+11 ;;^UTILITY(U,$J,358.3,25146,1,2,0)
+12 ;;=2^Inpt TH Pharm Mgmt
+13 ;;^UTILITY(U,$J,358.3,25146,1,4,0)
+14 ;;=4^G0459
+15 ;;^UTILITY(U,$J,358.3,25147,0)
+16 ;;=G0446^^88^1130^7^^^^1
+17 ;;^UTILITY(U,$J,358.3,25147,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,25147,1,2,0)
+20 ;;=2^Annual Intense Bhv Tx for Cardio Dx,15 min
+21 ;;^UTILITY(U,$J,358.3,25147,1,4,0)
+22 ;;=4^G0446
+23 ;;^UTILITY(U,$J,358.3,25148,0)
+24 ;;=G0447^^88^1130^13^^^^1
+25 ;;^UTILITY(U,$J,358.3,25148,1,0)
+26 ;;=^358.31IA^4^2
+27 ;;^UTILITY(U,$J,358.3,25148,1,2,0)
+28 ;;=2^Bhv Counsel for Obesity,15 min
+29 ;;^UTILITY(U,$J,358.3,25148,1,4,0)
+30 ;;=4^G0447
+31 ;;^UTILITY(U,$J,358.3,25149,0)
+32 ;;=G0506^^88^1130^17^^^^1
+33 ;;^UTILITY(U,$J,358.3,25149,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,25149,1,2,0)
+36 ;;=2^Comp Assmt Care Plan CCM Svc
+37 ;;^UTILITY(U,$J,358.3,25149,1,4,0)
+38 ;;=4^G0506
+39 ;;^UTILITY(U,$J,358.3,25150,0)
+40 ;;=G0513^^88^1130^57^^^^1
+41 ;;^UTILITY(U,$J,358.3,25150,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,25150,1,2,0)
+44 ;;=2^Prolong Prev Outpt Svc,1st 30 min
+45 ;;^UTILITY(U,$J,358.3,25150,1,4,0)
+46 ;;=4^G0513
+47 ;;^UTILITY(U,$J,358.3,25151,0)
+48 ;;=G0514^^88^1130^58^^^^1
+49 ;;^UTILITY(U,$J,358.3,25151,1,0)
+50 ;;=^358.31IA^4^2
+51 ;;^UTILITY(U,$J,358.3,25151,1,2,0)
+52 ;;=2^Prolong Prev Outpt Svc,Ea Addl 30 min
+53 ;;^UTILITY(U,$J,358.3,25151,1,4,0)
+54 ;;=4^G0514
+55 ;;^UTILITY(U,$J,358.3,25152,0)
+56 ;;=G2086^^88^1130^51^^^^1
+57 ;;^UTILITY(U,$J,358.3,25152,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,25152,1,2,0)
+60 ;;=2^Outpt Based Opioid Tx,70 min
+61 ;;^UTILITY(U,$J,358.3,25152,1,4,0)
+62 ;;=4^G2086
+63 ;;^UTILITY(U,$J,358.3,25153,0)
+64 ;;=G2087^^88^1130^50^^^^1
+65 ;;^UTILITY(U,$J,358.3,25153,1,0)
+66 ;;=^358.31IA^4^2
+67 ;;^UTILITY(U,$J,358.3,25153,1,2,0)
+68 ;;=2^Outpt Based Opioid Tx,60 min
+69 ;;^UTILITY(U,$J,358.3,25153,1,4,0)
+70 ;;=4^G2087
+71 ;;^UTILITY(U,$J,358.3,25154,0)
+72 ;;=G2088^^88^1130^52^^^^1
+73 ;;^UTILITY(U,$J,358.3,25154,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,25154,1,2,0)
+76 ;;=2^Outpt Based Opioid Tx,Ea Addl 30 min
+77 ;;^UTILITY(U,$J,358.3,25154,1,4,0)
+78 ;;=4^G2088
+79 ;;^UTILITY(U,$J,358.3,25155,0)
+80 ;;=U07.1^^89^1131^1
+81 ;;^UTILITY(U,$J,358.3,25155,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,25155,1,3,0)
+84 ;;=3^Confirmed COVID-19
+85 ;;^UTILITY(U,$J,358.3,25155,1,4,0)
+86 ;;=4^U07.1
+87 ;;^UTILITY(U,$J,358.3,25155,2)
+88 ;;=^5159070
+89 ;;^UTILITY(U,$J,358.3,25156,0)
+90 ;;=U09.9^^89^1131^2
+91 ;;^UTILITY(U,$J,358.3,25156,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,25156,1,3,0)
+94 ;;=3^Post COVID-19 Condition,Unspec
+95 ;;^UTILITY(U,$J,358.3,25156,1,4,0)
+96 ;;=4^U09.9
+97 ;;^UTILITY(U,$J,358.3,25156,2)
+98 ;;=^5161298
+99 ;;^UTILITY(U,$J,358.3,25157,0)
+100 ;;=Z20.822^^89^1132^1
+101 ;;^UTILITY(U,$J,358.3,25157,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,25157,1,3,0)
+104 ;;=3^Contact w/ & Exposure to COVID-19
+105 ;;^UTILITY(U,$J,358.3,25157,1,4,0)
+106 ;;=4^Z20.822
+107 ;;^UTILITY(U,$J,358.3,25157,2)
+108 ;;=^5160187
+109 ;;^UTILITY(U,$J,358.3,25158,0)
+110 ;;=J20.8^^89^1133^1
+111 ;;^UTILITY(U,$J,358.3,25158,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,25158,1,3,0)
+114 ;;=3^Bronchitis,Acute d/t Other Spec Organisms
+115 ;;^UTILITY(U,$J,358.3,25158,1,4,0)
+116 ;;=4^J20.8
+117 ;;^UTILITY(U,$J,358.3,25158,2)
+118 ;;=^5008194
